➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Boehringer Ingelheim
Mallinckrodt
McKesson
Johnson and Johnson

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: IBRUTINIB

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

IBRUTINIB

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-070-28 28 CAPSULE in 1 BOTTLE, PLASTIC (57962-070-28)
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-140-09 90 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-09)
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-140-12 120 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-12)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
AstraZeneca
Moodys
McKesson